Your Messages Inbox
Most Viewed Abstracts
1. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 2. Omega-3 fatty acids for bipolar disorder 3. Is folic acid good for everyone 4. ACS Releases Guidelines for HPV Vaccination 5. Vitamin D - A review Free full text
Your Article Summary
See Latest ArticlesEmergency Influenza Drug
JAMA, 11/25/09
Kuehn BM – The authorization allows use of the drug in hospitalized pediatric or adult patients only if the patient is not responding to oral or inhaled antiviral therapy or when nonintravenous drug administration is not feasible or likely to be reliable. It may also be used, but only in adult patients, when a clinician determines that intravenous therapy is appropriate for other reasons.
Related Articles
Updated influenza antiviral drug recommendations provided by CDC, FDA
American Pharmacists Association, 10/14/09
Relevance Score: 69%
Streptococcus pneumoniae and Haemophilus influenzae at the initial stage of influenza
Pediatrics International, 10/16/09
Relevance Score: 68%
Novartis completes shipment of US supply of Fluvirin seasonal influenza vaccine
Novartis, 10/07/09
Relevance Score: 68%
Update on 2009 pandemic influenza A (H1N1) virus
Cleveland Clinic Journal of Medicine, 10/05/09
Relevance Score: 68%
Large-Scale Sequence Analysis of M Gene of Influenza A Viruses from Different Species: Mechanisms for Emergence and Spread of Amantadine Resistance
Antimicrobial Agents and Chemotherapy, 10/01/09
Relevance Score: 68%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Capecitabine in combination with oxaliplatin or irinotecan in elderly patients with advanced colorectal cancer: results of a randomized phase II study
Annals of Oncology, 03/17/10
Relationship between HIV/Highly Active Antiretroviral Therapy (HAART)-Associated Lipodystrophy Syndrome and Stavudine-Triphosphate Intracellular Levels in Patients with Stavudine-Based Antiretroviral Regimens
Clinical Infectious Diseases, 03/17/10
A comparison of efficacy and safety of vildagliptin and gliclazide in combination with metformin in patients with Type 2 diabetes inadequately controlled with metformin alone: a 52-week, randomized study
Diabetic Medicine, 03/17/10
Article Search
Sponsor
Sponsor